Literature DB >> 16546096

Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells.

Alessio Delogu1, Alexandra Schebesta, Qiong Sun, Katharina Aschenbrenner, Thomas Perlot, Meinrad Busslinger.   

Abstract

The transcription factor Pax5 represses lineage-inappropriate genes and activates B cell-specific genes in B lymphocytes. By identifying 110 Pax5-repressed genes, we now demonstrate that Pax5 downregulates diverse biological activities including receptor signaling, cell adhesion, migration, transcriptional control, and cellular metabolism at B cell commitment. The T lymphoid or myeloid expression of these genes demonstrates that Pax5(-/-) pro-B cells and common lymphoid progenitors display lymphoid and myeloid promiscuity of gene expression. These lineage-inappropriate genes require continuous Pax5 activity for their repression, as they are reactivated in committed pro-B cells and mature B cells following conditional Pax5 deletion. Pax5-repressed genes are also reexpressed in plasma cells, which depend for normal function on Cd28 and Ccr2 reactivation. The loss of Pax5 during terminal differentiation thus contributes to the plasma cell transcription program. Finally, ectopic expression of the Pax5-repressed chemokine gene Ccl3 in B cells results in increased osteoclast formation and bone loss, demonstrating that Pax5-mediated gene repression is essential for normal homeostasis of hematopoietic development.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16546096     DOI: 10.1016/j.immuni.2006.01.012

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  120 in total

1.  The B-cell identity factor Pax5 regulates distinct transcriptional programmes in early and late B lymphopoiesis.

Authors:  Roger Revilla-I-Domingo; Ivan Bilic; Bojan Vilagos; Hiromi Tagoh; Anja Ebert; Ido M Tamir; Leonie Smeenk; Johanna Trupke; Andreas Sommer; Markus Jaritz; Meinrad Busslinger
Journal:  EMBO J       Date:  2012-06-05       Impact factor: 11.598

Review 2.  Eosinophils: important players in humoral immunity.

Authors:  C Berek
Journal:  Clin Exp Immunol       Date:  2015-09-28       Impact factor: 4.330

Review 3.  Effect of Immunosuppressive Drugs on Humoral Allosensitization after Kidney Transplant.

Authors:  Olivier Thaunat; Alice Koenig; Claire Leibler; Philippe Grimbert
Journal:  J Am Soc Nephrol       Date:  2016-02-12       Impact factor: 10.121

4.  The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-κB ligand (RANKL)-induced osteoclast differentiation.

Authors:  Masakazu Kogawa; Koji Hisatake; Gerald J Atkins; David M Findlay; Yuichiro Enoki; Tsuyoshi Sato; Peter C Gray; Yukiko Kanesaki-Yatsuka; Paul H Anderson; Seiki Wada; Naoki Kato; Aya Fukuda; Shigehiro Katayama; Masafumi Tsujimoto; Tetsuya Yoda; Tatsuo Suda; Yasushi Okazaki; Masahito Matsumoto
Journal:  J Biol Chem       Date:  2013-08-29       Impact factor: 5.157

5.  Critical role of IRF-5 in regulation of B-cell differentiation.

Authors:  Chunyang Lien; Chee-Mun Fang; David Huso; Ferenc Livak; Runqing Lu; Paula M Pitha
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-22       Impact factor: 11.205

Review 6.  Affinity of antigen encounter and other early B-cell signals determine B-cell fate.

Authors:  Micah J Benson; Loren D Erickson; Michael W Gleeson; Randolph J Noelle
Journal:  Curr Opin Immunol       Date:  2007-04-12       Impact factor: 7.486

7.  Expression pattern of XBP1(S) in human B-cell lymphomas.

Authors:  Lorena Maestre; Reuben Tooze; Marta Cañamero; Santiago Montes-Moreno; Rocio Ramos; Gina Doody; May Boll; Sharon Barrans; Sara Baena; Miguel Angel Piris; Giovanna Roncador
Journal:  Haematologica       Date:  2009-01-27       Impact factor: 9.941

8.  B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.

Authors:  Diana Cozma; Duonan Yu; Suchita Hodawadekar; Anna Azvolinsky; Shannon Grande; John W Tobias; Michele H Metzgar; Jennifer Paterson; Jan Erikson; Teresa Marafioti; John G Monroe; Michael L Atchison; Andrei Thomas-Tikhonenko
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

Review 9.  Re-thinking the functions of IgA(+) plasma cells.

Authors:  Jennifer L Gommerman; Olga L Rojas; Jörg H Fritz
Journal:  Gut Microbes       Date:  2014

Review 10.  Augmentation of antibody responses by retinoic acid and costimulatory molecules.

Authors:  A Catharine Ross; Qiuyan Chen; Yifan Ma
Journal:  Semin Immunol       Date:  2008-09-25       Impact factor: 11.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.